Nyxoah Announces Issuance of First Tranche of Convertible Bonds GlobeNewswire December 19, 2025 Nyxoah Announces Issuance of First Tranche of Convertible Bonds Mont-Saint-Guibert, Belgium – December 19, 2025, 10:05pm CET / 4:05pm ET – Nyxoah SA (Euronext Brussels/Nasdaq: NYXH) (“Nyxoah” or the “Company“), a medical technology company focused on the development and commercialization of innovative […]

Rocket Lab Awarded $816M Prime Contract to Build Missile- Defense Satellite Constellation for U.S. Space Force Rocket Lab's largest contract to date solidifies its position as a disruptive force in national security space, redefining the speed and efficiency of satellite production and challenging legacy aerospace primes GlobeNewswire December 19, 2025 LONG BEACH, Calif., Dec. 19,

Lifeward Appoints Bob Marshall as Chairman of the Board GlobeNewswire December 19, 2025 MARLBOROUGH, Mass. and YOKNEAM ILLIT, Israel, Dec. 19, 2025 (GLOBE NEWSWIRE) — Lifeward Ltd., (Nasdaq: LFWD) (“Lifeward” or the “Company”), a global leader in innovative medical technology designed to transform the lives of people with physical limitations or disabilities, announced today that

(NasdaqGM:VHCPU), Fort Lauderdale, Florida, Dec. 19, 2025 (GLOBE NEWSWIRE) — Vine Hill Capital Investment Corp. II (the “Company“), a special purpose acquisition company, today announced the closing of its upsized initial public offering of 23,000,000 units at a price of $10.00 per unit, including 3,000,000 units issued pursuant to the exercise of the underwriters' over-allotment

(TSX-V:NRX),(Frankfurt:J90),(Boerse Stuttgart – Freiverkehr:J90),(Boerse Muenchen – Freiverkehr:J90),(OTC US:NRXBF),(Other OTC:NRXBF), TORONTO and HAIFA, Israel, Dec. 19, 2025 (GLOBE NEWSWIRE) — NurExone Biologic Inc. (TSXV: NRX) (OTCQB: NRXBF) (FSE: J90) (“NurExone” or the “Company“) today announced new laboratory data demonstrating that its proprietary exosomes can significantly reduce inflammatory activity compared to untreated cells and cells treated with

NurExone Reports Anti-Inflammatory Activity of Its Exosomes in Lab Analysis Reducing inflammation helps create a regenerative environment in the Central Nervous System GlobeNewswire December 19, 2025 TORONTO and HAIFA, Israel, Dec. 19, 2025 (GLOBE NEWSWIRE) — NurExone Biologic Inc. (TSXV: NRX) (OTCQB: NRXBF) (FSE: J90) (“NurExone” or the “Company“) today announced new laboratory data demonstrating

Vine Hill Capital Investment Corp. II Announces Closing of Upsized $230 Million Initial Public Offering GlobeNewswire December 19, 2025 Fort Lauderdale, Florida, Dec. 19, 2025 (GLOBE NEWSWIRE) — Vine Hill Capital Investment Corp. II (the “Company“), a special purpose acquisition company, today announced the closing of its upsized initial public offering of 23,000,000 units at

Vancouver, British Columbia–(Newsfile Corp. – December 19, 2025) – Pacific Bay Minerals Ltd. (TSXV: PBM) “Pacific Bay” or the “Company”) reports that the Company’s proposed acquisition of the Pereira Velho project in Alagoas State, Brazil, as initially disclosed on January 7th, 2025, will not be proceeding. The vendor, Appian Capital Advisory LLP, has optioned the

(NYSE:KLAR), NEW YORK, Dec. 19, 2025 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of Klarna Group plc (NYSE: KLAR) resulting from allegations that Klarna may have issued materially misleading business information to the investing public. SO WHAT: If

(NASDAQ:ACRS), WAYNE, Pa., Dec. 19, 2025 (GLOBE NEWSWIRE) — Aclaris Therapeutics, Inc. (NASDAQ: ACRS), a clinical-stage biopharmaceutical company focused on developing novel product candidates for immuno-inflammatory diseases, today announced it has been added to the Nasdaq Biotechnology Index (NASDAQ: NBI), effective at the close of trading today, December 19, 2025. The NBI is designed to